Material and Method
In this study, 559 patients with untreated non-gonococcal urethritis were each given one intramuscular injection of 1 g. streptomycin sulphate and an additional drug as follows:
No. of Cases Drug Dosage 66 Madribon.
I g. daily for 5 days
Those on RO 4-4393 swallowed their tablets under observation in the clinic by the doctor or nurse.
The patients were followed up for 3 months. If at the end of that period they were free from signs and symptoms, no further treatment was required, their urine was clear, and prostatic fluids and serology were normal, they were considered to be cured.
Results
The results (Table) with sulphamethoxy-pyridazine were not as good as they had been in 1959 (Jelinek) when the cure rate was 82-3 per cent., whereas now it was down to 61 per cent. This is not unlike the figures Willcox (1962) obtained with similar treatment. Prebble (1962) There were other puzzling features in these results which may cast some doubt on their value: in patients who received only 1 g. RO 4-4393 the cure rate was 10 per cent. better than in those who had 2 g.-yet the default rate was higher in patients who TREATMENT OF NON-GONOCOCCAL URETHRITIS had 2 g. compared with those who had only 1 g. One can only speculate about the reasons for th9e paradoxical findings. Perhaps the numbers of patients in the groups investigated are too small to have any statistical significance or the whole evaluation of the therapy of non-gonococcal urethritis will have to be reconsidered (Fowler, 1958) .
Side-effects.-There were no toxic effects with the conventional sulphonamides (Madribon, Durenate, and sulphamethoxy-pyridazine). With RO 4-4393 two patients vomited, one had diarrhoea, and one had dizziness, but all these reactions were transient and slight.
Although the overall results are not very good, the cost has remained low and the treatment comparatively safe. The recent release of cheaply imported tetracyclines from Italy and Poland seriously undercuts the price of the combined streptomycin with sulphonamides treatment.
Summary
A series of 599 patients with untreated nongonococcal urethritis were given one intramuscular injection of streptomycin sulphate 1 g. and additional long-acting sulphonamides.
The single dose long-acting Roche product, RO 4-4393, gave results similar to other long-acting sulphonamides.
Overall results were not good (only just over 50 per cent. cure rate) and they were considerably worse than those obtained in a similar series five years ago. 
